Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.
Judo Bio has raised $75.0M in total funding. The most recent round was Series A. The last funding was announced in October 2024.
Judo Bio's investors include TCG, The Column Group, Digitalis Ventures, Atlas Venture, Alexandria Venture Investments.
Judo Bio is headquartered in Cambridge, United States.
Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.
Judo Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Judo Bio — Funding & Investors." VCBacked, October 7, 2024, https://www.vcbacked.co/company/judo-bio. Accessed November 13, 2026.
VCBacked. (2024). Judo Bio — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/judo-bio
{{cite web |title=Judo Bio — Funding & Investors |url=https://www.vcbacked.co/company/judo-bio |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Judo Bio? Request a listing update